
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health Langfristiger Schuldenstrom 2011-2026 | SYNH
Langfristiger Schuldenstrom Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 43.1 M | 42.1 M | 38.1 M | 50.1 M | 25 M | 11.9 M | 29.8 M | 4.25 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 50.1 M | 4.25 M | 30.5 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 25.38 | 2.19 % | $ 705 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Danaher Corporation
DHR
|
199 M | $ 196.17 | 2.7 % | $ 140 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.27 | 2.23 % | $ 492 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 17.97 | 1.7 % | $ 958 M | ||
|
Guardant Health
GH
|
27.7 M | $ 94.63 | 1.43 % | $ 11.9 B | ||
|
DexCom
DXCM
|
21.6 M | $ 65.54 | 3.85 % | $ 25.6 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 109.05 | 1.76 % | $ 8.99 B | ||
|
Illumina
ILMN
|
79 M | $ 128.09 | 1.3 % | $ 20.4 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
93 M | $ 174.65 | 2.42 % | $ 30 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 80.09 | 2.57 % | $ 5.41 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 176.44 | 4.03 % | $ 8.75 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 524.94 | 3.23 % | $ 15.1 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 318.47 | 3.81 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.84 | 2.0 % | $ 448 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.37 | 3.85 % | $ 1.07 B | ||
|
Biodesix
BDSX
|
719 K | $ 14.52 | -0.08 % | $ 1.88 B | ||
|
Natera
NTRA
|
7.64 M | $ 212.81 | 1.69 % | $ 20.9 B | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
Pacific Biosciences of California
PACB
|
448 K | $ 1.49 | 3.12 % | $ 447 M | ||
|
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | ||
|
Precipio
PRPO
|
410 K | $ 27.77 | -2.56 % | $ 44.6 M | ||
|
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | ||
|
Personalis
PSNL
|
7.7 M | $ 6.48 | 5.02 % | $ 384 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 274.08 | 1.83 % | $ 22.8 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.68 | -0.37 % | $ 87 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.15 | -0.46 % | $ 4.94 M | ||
|
BioNano Genomics
BNGO
|
697 K | $ 1.18 | 0.85 % | $ 6.43 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.0 | 0.25 % | $ 8.85 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |